American Diabetes Association

646 articles with American Diabetes Association

• Sanofi Canada continues to invest in modern diabetes research to improve outcomes for people living with diabetes

  7/2/2021

  Building on a strong legacy and history in diabetes, Sanofi Canada participated in the 81st Scientific Sessions hosted by the American Diabetes Association.

• Early Use Of Sotagliflozin Provides Benefits For People With Type 2 Diabetes With Chronic Kidney Disease Or Heart Failure

  6/29/2021

  Results from two large clinical trials show significant and early benefits from sotagliflozin, a drug that inhibits sodium-glucose transport protein 2 and sodium-glucose transport protein 1 in reducing heart failure, heart attack, and stroke—major problems in people with diabetes.

• Hanmi Pharmaceutical finds new innovative potential for "Efpeglenatide"

  6/29/2021

  Hanmi Pharmaceutical recently announced that its new, long-acting diabetes biologic drug, efpeglenatide, was shown to significantly reduce incidences of major adverse cardiovascular events and kidney disease in the results of its global, large-scale clinical trial with more than 4,000 patients.

• The American Diabetes Association and Partners Commemorate 100th Anniversary of Discovery of Insulin and Look to the Next 100 Years for Breakthroughs Ahead

  6/28/2021

  The American Diabetes Association®, along with the nation's leading diabetes organizations, unveiled Let's Talk Insulin , a campaign commemorating the 100th anniversary of the discovery of insulin.

• Liraglutide And Insulin More Effective In Maintaining Average Blood Glucose Levels Than Other Common Diabetes Drugs

  6/28/2021

  Investigators sponsored by the National Institutes of Health announced findings from the largest and longest study comparing the effectiveness of common medications to treat type 2 diabetes.

• New Soliqua 100/33 data shows improved blood sugar control without weight gain versus premixed insulin

  6/28/2021

  A new study of Soliqua® 100/33 100 Units/mL and 33 mcg/mL, iGlarLixi, met its two primary endpoints and all key secondary endpoints in a head-to-head comparison against premixed insulin in adults living with type 2 diabetes, the most common form of diabetes, uncontrolled on insulin and one or two oral anti-diabetic medicines.

• Income-Related Inequalities In Diabetes Have Widened Over Past Decade, CDC Study Finds

  6/28/2021

  A new study from researchers at the Centers for Disease Control and Prevention reveal income-related inequalities in rates of diabetes exist between 2001 and 2018.

• 

  Lilly, Novo Nordisk Present Promising Data in Type 2 Diabetes

  6/28/2021

  Eli Lilly and Novo Nordisk published their data in The Lancet  Diabetes & Endocrinology and presented them at the ADA conference.

• Dapagliflozin is Well Tolerated in Hospitalized COVID-19 Patients

  6/27/2021

  DARE-19 is the first large randomized clinical trial to assess sodium-glucose cotransporter-2 inhibitors in patients with and without type 2 diabetes hospitalized with COVID-19.

• Lilly's SURPASS-1 results published in The Lancet show tirzepatide's superior A1C and body weight reductions versus placebo in adults with type 2 diabetes

  6/26/2021

  Tirzepatide led to superior A1C and body weight reductions from baseline across all three doses in adults with type 2 diabetes after 40 weeks of treatment in Eli Lilly and Company's SURPASS-1 monotherapy clinical trial evaluating the efficacy and safety of tirzepatide compared to placebo.

• Unmanaged Diabetes Associated With Greater COVID-19 Severity

  6/25/2021

  A new study reveals unmanaged diabetes is a key factor in COVID-19 severity and complications, particularly among Hispanic and Latinx populations.

• American Diabetes Association Focuses On Health Disparities Deepened By Pandemic During 81st Scientific Sessions

  6/25/2021

  The American Diabetes Association® is highlighting the latest understanding of how to address health disparities laid bare by the pandemic at the virtual 81st Scientific Sessions.

• Diabetes Shown As Strongest Indicator Of Covid-19 Severity In Japanese Patients

  6/25/2021

  Findings of a new study show diabetes was the main risk factor for the accelerated advancement to a severe state in Japanese COVID-19 patients.

• Important Updates to the 2021 Standards of Medical Care in Diabetes Issued by American Diabetes Association Experts

  6/16/2021

  The American Diabetes Association® issued important updates to the 2021 Standards of Medical Care in Diabetes, in annotations as the Living Standards of Care.

• American Diabetes Association, with Visionary Partners VSP Vision Care and Regeneron Launch "The Next Step Eye Challenge" Campaign for Healthy Vision Month in May

  5/20/2021

  Over 34 million American adults currently live with diabetes and an additional 88 million are living with prediabetes, yet 85% of them do not know they have it.

• COVID Fears Kept One in Five People With Diabetes Away From the Doctor During Pandemic

  5/18/2021

  A new study released by the American Diabetes Association® in partnership with dQ&A, finds that growing numbers of people with diabetes have not only been forced to put off needed medical care since the outbreak of COVID-19, but that alarming numbers are struggling to manage their blood glucose levels.

• Sun Life partners with American Diabetes Association to support Project Power youth health program

  5/6/2021

  Sun Life has become a national sponsor of Project Power, a youth health and fitness program offered by the American Diabetes Association®.

• The American Diabetes Association® and Yumlish Make Virtual National DPP Program Available to 88 Million Americans with Prediabetes

  4/8/2021

  Building on three years of success, the American Diabetes Association announced a new partnership with Yumlish, a virtual service platform, as part of the ADA's work on the National Diabetes Prevention Program.

• The American Diabetes Association® Launches: Better Choices for Life

  3/30/2021

  The American Diabetes Association is pleased to announce the launch of the Better Choices for Life program. The program is designed to aid shoppers in making better choices while shopping and is currently in its pilot stage.

• The Pfizer Foundation, American Diabetes Association Partner to Bring Healthy Food and Diabetes Support to Underserved Community to Address Health Inequities

  3/25/2021

  Social Determinants of Health grant will provide community gardens and diabetes support to people in low-income areas in Alabama